| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000001521 |
| Receipt No. | R000001495 |
| Official scientific title of the study | Assessment of Lipophilic vs HydroPhilic Statin Therapy in Acute Myocardial Infarction: ALPS-AMI |
| Date of disclosure of the study information | 2008/11/25 |
| Last modified on | 2016/12/20 (Ver. 5) |
| Basic information | ||
| Official scientific title of the study | Assessment of Lipophilic vs HydroPhilic Statin Therapy in Acute Myocardial Infarction: ALPS-AMI | |
| Title of the study (Brief title) | Assessment of Statin Therapy in AMI | |
| Region |
|
|
| Condition | |||
| Condition | Acute myocardial infarction | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To evaluate efficacy and safety of either hydrophilic or lipophilic statins for optimal management of dyslipidemia in patients with acute myocardial infarction |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Death from any cause, cardiovascular death, myocardial infarction, stroke, and myocardial ischemia, which requires coronary intervention and/or coronary artery bypass grafting |
| Key secondary outcomes | Hospital admission for heart failure, and any other vascular events |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Hydrophilic statin | |
| Interventions/Control_2 | Lipophilic statin | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients admitted with acute myocardial infarction (AMI), accompanied with serum low-density lipoprotein cholesterol level at 70 mg/dl or above. The diagnosis of AMI should be done following the AHA guideline, which has been documented in Circulation 2007: 116, 2634-2653. | |||
| Key exclusion criteria | 1. Advanced liver dysfunction
2. Renal failure 3. Previous history of the side effects associated with statins 4. Planned surgery for coronary artery bypass grafting 5. Known malignant disease 6. Absence of written informed consent 7. LDL cholesterol level < 70 mg/dl 8. Any other rational reason for exclusion |
|||
| Target sample size | 500 | |||
| Research contact person | |
| Name of lead principal investigator | Uichi Ikeda |
| Organization | Shinshu University School of Medicine |
| Division name | Department of Cardiovascular Medicine |
| Address | Asahi 3-1-1, Matsumoto, Nagano |
| TEL | 0263-37-3486 |
| alps@shinshu-u.ac.jp | |
| Public contact | |
| Name of contact person | Research Center of the ALPS-AMI Study |
| Organization | Shinshu University School of Medicine |
| Division name | Department of Cardiovascular Medicine |
| Address | Asahi, 3-1-1, Matsumoto, Nagano |
| TEL | 0263-37-3486 |
| Homepage URL | |
| alps@shinshu-u.ac.jp | |
| Sponsor | |
| Institute | Department of Cardiovascular Medicine, Shinshu University School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Research Fund Donation |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 信州大学医学部附属病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000001495 |